These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 23365134)
1. TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells. Shinojima N; Hossain A; Takezaki T; Fueyo J; Gumin J; Gao F; Nwajei F; Marini FC; Andreeff M; Kuratsu J; Lang FF Cancer Res; 2013 Apr; 73(7):2333-44. PubMed ID: 23365134 [TBL] [Abstract][Full Text] [Related]
2. ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts. Wildburger NC; Wood PL; Gumin J; Lichti CF; Emmett MR; Lang FF; Nilsson CL J Proteome Res; 2015 Jun; 14(6):2511-9. PubMed ID: 25880480 [TBL] [Abstract][Full Text] [Related]
3. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. Shimizu Y; Gumin J; Gao F; Hossain A; Shpall EJ; Kondo A; Parker Kerrigan BC; Yang J; Ledbetter D; Fueyo J; Gomez-Manzano C; Lang FF J Neurosurg; 2022 Mar; 136(3):757-767. PubMed ID: 34450587 [TBL] [Abstract][Full Text] [Related]
4. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864 [TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545 [TBL] [Abstract][Full Text] [Related]
6. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410 [TBL] [Abstract][Full Text] [Related]
8. TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma. Egea V; von Baumgarten L; Schichor C; Berninger B; Popp T; Neth P; Goldbrunner R; Kienast Y; Winkler F; Jochum M; Ries C Cell Death Differ; 2011 May; 18(5):853-63. PubMed ID: 21127499 [TBL] [Abstract][Full Text] [Related]
9. MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5. Wang H; Tan L; Dong X; Liu L; Jiang Q; Li H; Shi J; Yang X; Dai X; Qian Z; Dong J Aging (Albany NY); 2020 Jul; 12(13):13647-13667. PubMed ID: 32632040 [TBL] [Abstract][Full Text] [Related]
10. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Yong RL; Shinojima N; Fueyo J; Gumin J; Vecil GG; Marini FC; Bogler O; Andreeff M; Lang FF Cancer Res; 2009 Dec; 69(23):8932-40. PubMed ID: 19920199 [TBL] [Abstract][Full Text] [Related]
11. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell. Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201 [TBL] [Abstract][Full Text] [Related]
12. Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells. Srinivasan VM; Gumin J; Camstra KM; Chen SR; Johnson JN; Shimizu Y; Parker Kerrigan BC; Shpall EJ; Lang FF; Kan P J Neurosurg; 2020 Oct; 133(4):1182-1190. PubMed ID: 31491769 [TBL] [Abstract][Full Text] [Related]
13. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998 [TBL] [Abstract][Full Text] [Related]
14. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7. Liang H; Wang Q; Wang D; Zheng H; Kalvakolanu DV; Lu H; Wen N; Chen X; Xu L; Ren J; Guo B; Zhang L Biochem Pharmacol; 2020 Oct; 180():114118. PubMed ID: 32585142 [TBL] [Abstract][Full Text] [Related]
15. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene. Tsuda H; Wada T; Yamashita T; Hamada H J Gene Med; 2005 Oct; 7(10):1322-34. PubMed ID: 15926193 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. Balyasnikova IV; Ferguson SD; Sengupta S; Han Y; Lesniak MS PLoS One; 2010 Mar; 5(3):e9750. PubMed ID: 20305783 [TBL] [Abstract][Full Text] [Related]
17. PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling. Uthanaphun T; Manochantr S; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P Biosci Rep; 2024 May; 44(5):. PubMed ID: 38687607 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived mesenchymal stem cells expressing BMP2 suppress glioma stem cell growth and stemness through Bcl-2/Bax signaling. Feng J; Yao Z; Yang H; Ma J; Zhong X; Qin Y; Li J J Cancer Res Ther; 2022 Dec; 18(7):2033-2040. PubMed ID: 36647967 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Lee HK; Finniss S; Cazacu S; Bucris E; Ziv-Av A; Xiang C; Bobbitt K; Rempel SA; Hasselbach L; Mikkelsen T; Slavin S; Brodie C Oncotarget; 2013 Feb; 4(2):346-61. PubMed ID: 23548312 [TBL] [Abstract][Full Text] [Related]
20. TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. Zhou S J Cell Biochem; 2011 Jun; 112(6):1651-60. PubMed ID: 21344492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]